Matthew Dumbleton

Matthew Dumbleton is an accomplished account executive at Bardy Diagnostics, Inc. since August 2022, bringing extensive experience in the medical and sales sectors. Prior to this role, Dumbleton served as a digital solutions specialist and territory manager at Ormco from September 2017 to August 2022. Earlier positions include territory manager and sales associate at Bausch + Lomb (February 2014 - June 2017), ambassador at UGA Discover Abroad (August 2012 - January 2014), and several internships with Dow AgroSciences, ABM Industries, and OurEarth.org. Dumbleton holds a B.S. in Environmental Economics and Management with a minor in Marketing from The University of Georgia, where studies were conducted from 2010 to 2013, following core curriculum studies at Florida State University from 2009 to 2010. Early involvement as a coach with Atlanta Youth Lacrosse underscores Dumbleton's commitment to youth development and community engagement.

Location

Birmingham, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Diagnostic Cardiology at Baxter - U.S.

1 followers

Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Itsunique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape.Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses.Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.